Abstract:The alternative splicing of PML precursor mRNA gives rise to various PML isoforms, yet their expression profile in breast cancer cells remains uncharted. We discovered that PML1 is the most abundant isoform in all breast cancer subtypes, and its expression is associated with unfavorable prognosis in estrogen receptor-positive (ER+) breast cancers. PML depletion reduces cell proliferation, invasion, and stemness, while heterologous PML1 expression augments these processes and fuels tumor growth and resistance to fulvestrant, an FDA-approved drug for ER+ breast cancer, in a mouse model. Moreover, PML1, rather than the well-known tumor suppressor isoform PML4, rescues the proliferation of PML knockdown cells. ChIP-seq analysis reveals significant overlap between PML-, ER-, and Myc-bound promoters, suggesting their coordinated regulation of target gene expression, including genes involved in breast cancer stem cells (BCSCs), such as JAG1 , KLF4 , YAP1 , SNAI1 , and MYC . Loss of PML reduces BCSC-related gene expression, and exogenous PML1 expression elevates their expression. Consistently, PML1 restores the association of PML with these promoters in PML -depleted cells. We identified a novel association between PML1 and WDR5, a key component of H3K4 methyltransferase (HMTs) complexes that catalyze H3K4me1 and H3K4me3. ChIP-seq analyses showed that the loss of PML1 reduces H3K4me3 in numerous loci, including BCSC-associated gene promoters. Additionally, PML1, not PML4, re-establishes the H3K4me3 mark on these promoters in PML -depleted cells. Significantly, PML1 is essential for recruiting WDR5, MLL1, and MLL2 to these gene promoters. Inactivating WDR5 by knockdown or inhibitors phenocopies the effects of PML1 loss, reducing BCSC-related gene expression and tumorsphere formation and enhancing fulvestrant's anticancer activity. Our findings challenge the conventional understanding of PML as a tumor suppressor, redefine its role as a promoter of tumor growth in breast cancer, and offer new insights into the unique roles of PML isoforms in breast cancer.

PML protein isoforms and the RBCC/TRIM motif

Characterization of Endogenous Human Promyelocytic Leukemia Isoforms

Contribution of the C-Terminal Regions of Promyelocytic Leukemia Protein (pml) Isoforms Ii and V to Pml Nuclear Body Formation

Coiled-coil Domain of PML is Essential for the Aberrant Dynamics of PML-RARα, Resulting in Sequestration and Decreased Mobility of SMRT

Research Advances on Function of Promyelocytic Leukemia (PML) Protein

C-terminal motifs in PML isoforms critically regulate PML-NB formation.

Leukemia-associated Retinoic Acid Receptor Alpha Fusion Partners, PML and PLZF, Heterodimerize and Colocalize to Nuclear Bodies.

B1 Oligomerization Regulates PML Nuclear Body Biogenesis and Leukemogenesis

The Highly Conserved Region Within Exonuclease III-like in PML-I Regulates the Cytoplasmic Localization of PML-NBs

The Function of PML in P53-Dependent Apoptosis

PML is a constitutive component of chromatin domains enriched in repetitive elements and duplicated gene clusters in cancer cells

The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

PML Nuclear Bodies and Apoptosis.

PML3 Orchestrates the Nuclear Dynamics and Function of TIP60

Amino-Terminal Protein-Protein Interaction Motif (Poz-Domain) Is Responsible For Activities Of The Promyelocytic Leukemia Zinc Finger Retinoic Acid Receptor Alpha Fusion Protein

Characterization and functional analysis of chicken promyelocytic leukemia protein

Stabilization of PML Nuclear Localization by Conjugation and Oligomerization of SUMO-3.

Microtubule-associated Protein 1 Light Chain 3 Interacts with and Contributes to Growth Inhibiting Effect of PML.

Occurrence of Distinct PML-RAR-alpha Fusion Gene Isoforms in Patients with Acute Promyelocytic Leukemia Detected by Reverse Transcriptase/polymerase Chain Reaction.

Variant-Type Pml-Rar Alpha Fusion Transcript In Acute Promyelocytic Leukemia: Use Of A Cryptic Coding Sequence From Intron 2 Of The Rar Alpha Gene And Identification Of A New Clinical Subtype Resistant To Retinoic Acid Therapy

Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia